In this volume, we delve into relapse prevention strategies and how the combination of cognitive–behavioral therapy (CBT) and antidepressant continuation can cut the relapse risk for major depressive disorder in youth by roughly 50%. We also discuss the role of antipsychotics in treating youth with anorexia nervosa and the long-term effects of sertraline on pediatric growth and development. How does the association between dissociative effects and the response to ketamine manifest in youth with treatment-resistant depression? Finally, how significant are long-acting injectable antipsychotics in managing schizophrenia spectrum disorders in children and adolescents?
- Provider:Medical Academy, LLC
- Activity Link: https://psychopharmacologyinstitute.com/publication/cap-smart-takes-vol-15-2779?utm_source=PDF+CME+Program&utm_medium=PDF+CME+Program&utm_campaign=PDF+CME+Program
- Start Date: 2023-10-01 05:00:00
- End Date: 2023-10-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Knowledge, Learner Performance
- Provider Ship: Jointly Provided
- Registration: Limited